Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Session: Infections in Transplant and Hematologic Malignancy Patients, Part 1

161 - Prospective Study of Cytomegalovirus (CMV) Reactivation in Patients with Multiple Myeloma Receiving anti-CD38 and BCMA Therapies: An Interim Data Analysis

Thursday, October 17, 2024
2:15 PM – 2:30 PM US PT
Location: 408 A

    Presenting Author(s)

  • Emily Baneman, MD

    Assistant Professor
    Icahn School of Medicine at Mount Sinai
    New York, NY, United States

    Slides

    • Co-Author(s)

  • EM

    Erin Moshier

    Statistician
    TCI Biostatistics Shared Resource Facility, Institute for Healthcare Delivery Science, Department of Population Health Science & Policy, Icahn School of Medicine at Mount Sinai
    New York, NY, United States

  • LS

    Larysa Sanchez, MD

    Icahn School of Medicine at Mount Sinai
    New York, New York, United States

  • Meenakshi M. Rana, MD (she/her/hers)

    Associate Professor
    Icahn School of Medicine at Mount Sinai
    Scarsdale, NY, United States

  • SJ

    Samantha E. Jacobs, MD, MS

    Attending physician
    Icahn School of Medicine at Mount Sinai
    New York, New York, United States

Disclosure(s):
Emily Baneman, MD: Merck: Grant/Research Support
Erin Moshier: No financial relationships to disclose
Larysa Sanchez, MD: No financial relationships to disclose
Meenakshi M. Rana, MD: No financial relationships to disclose
Samantha E. Jacobs, MD, MS: Ansun Biopharma: Advisor/Consultant; Eurofins, Viracor, LLC.: Grant/Research Support